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Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296 S151NSAIDs and NSAID-speciﬁc inhibition of prostaglandin synthesis were
determined by colorimetric activity assays and EIAs. Gene- and protein
expression analyses were employed to determine the effects on chon-
drogenic extracellular matrix formation.
Results: COX-speciﬁcity of the NSAIDs was conﬁrmed and for subsequent
experiments NSAID concentrations were selected that resulted in similar
degrees of COX-1 or COX-2 inhibition. COX-1 speciﬁcNSAIDs inhibited Col2a1
and Col10a1 expression. Inhibition of COX-2 resulted in substantial decrease
of Col10a1 expression, while Col2a1 remained unaffected. To explain this
difference we determined the expression patterns of both COX enzymes as
well as speciﬁc prostaglandin synthesis during differentiation. COX-1 is
upregulated during late chondrogenic differentiation, whereas COX-2 is
brieﬂy expressed early in differentiation and increases again late in differ-
entiation. PGD2 and PGE2 faithfully followed the COX-2 expression pattern,
whereas PGF2a and TxB2 levels remained stably low. Furthermore, COX-2
inhibition resulted in decreased levels of all tested PGs, whereas COX-1
inhibition inhibited synthesis of all PGs, exept for PGD2, whichwas increased.
Conclusions: Our ﬁndings point towards a differential role for COX-
enzymes and PG-production in chondrogenic differentiation. Ongoing
research is focussing on further elucidating the functional partition of
cyclooxygenases and speciﬁc prostaglandin production. Our data add to
the pallet of possibilities for improving the collagen quality of cartilage
constructs for better outcome of cartilage regenerative approaches.
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BMP-2 AND BMP-7: DIFFERENTIAL REGULATION OF CHONDROGENIC
DIFFERENTIATION
M.J. Caron, T.J. Welting, D.A. Surtel, A. Cremers, M.M. Coolsen,
L.W. van Rhijn, P.J. Emans. Dept. Orthopaedic Surgery, Maastricht Univ.
Med. Ctr., Maastricht, NETHERLANDS
Purpose: Bone morphogenic protein (BMP)-2 and BMP-7 are known to
induce (ectopic) bone formation. The recombinant human versions of
these proteins are clinically approved and used to promote osteogenesis at
sites of poor fracture healing (non-unions) and as additional factors to
enhance integration of bone grafts. Recently, molecular studies have
shown that BMPs are also able to regulate the chondrogenic regenerative
potential. However, the differential inﬂuence of different BMPs on the
chondrogenesis of progenitor cells is unknown.
Methods: Equimolar concentrations of BMP-2 and BMP-7 were added
from the initiation of chondrogenic differentiation of ATDC5 and hBMSCs
onward. Chondrogenic markers (Col2a1, Sox9), chondrocyte hypertrophic
markers (Col10a1, RunX2) and endochondral regulatory mediators were
determined by gene- and protein expression analysis.
Results: Supplementing BMP-7 to chondrogenically differentiating ATDC5
cells resulted in an overall increased Col2a1 expression and decreased
chondrocyte hypertrophy. In contrast, BMP-2 dose-dependently increased
chondrocyte hypertrophic markers Col10a1 and RunX2, whereas Col2a1
levels did not differ from control conditions. This profound differential
action of BMP-2 and BMP-7 on ATDC5 endochondral differentiation could
also be conﬁrmed in hBMSC endochondral differentiation. Interestingly,
we found that COX-2 was speciﬁcally induced by BMP-2 and not by BMP-7
possibly explaining the differential hypertrophic actions these BMPs.
Conclusions: BMP-2 and BMP-7 show differential effects on the chon-
drogenic outcome of differentiating chondroprogenitor cells: BMP-2 acts
a speciﬁc inducer of chondrocyte hypertrophy, while BMP-7 appears to
increase or maintain chondrogenic potential. We are now establishing the
underlying mechanism which explains this striking differential effect. Our
results may provide novel leads to optimize cartilage regenerative tech-
niques on a differential BMP basis.
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ESTABLISHMENT OF NOVEL THREE-DIMENSIONAL CULTURE SYSTEM
FOR HUMAN CHONDROCYTES USING MICRO-SPACE PLATE
M. Hashizume, M. Mihara. Chugai Pharmaceutical Co., Ltd, Gotemba, Japan
Purpose: It has been reported that monolayer culture of human articular
chondrocytes results in dedifferentiation and loss of chondrogenic prop-
erty. Therefore, the dedifferentiation is a big problem when the inﬂuenceof cytokines and drugs were evaluated. In order to solve this problem, we
performed a novel three-dimensional culture system for human chon-
drocytes using micro-space plates compared with monolayer culture.
Methods: The micro-space plate has regularly arranged 200 mm100
mm50 mm square compartments on its surface. Human articular chon-
drocytes were cultured in ﬂat plates ormicro-space plates for 1 week. After
culture, the level of collagen 1A1 (COL1A1) and aggrecan mRNA expres-
sions were measured by real-time PCR, and cartilage matrix production
was assessed by alcian blue staining. Furthermore, chondrocytes were
cultured with IL-1b, IL-6+soluble IL-6 receptor (sIL-6R) in the presence or
absence of high molecular hyaluronic acid (HA) for additional 24 h and
then the production of MMP-3 in cell supernatant was measured by ELISA.
Results: At the same passage of cells, human articular chondrocytes grown
on micro-space plates in clusters after 5-7 days’ culture, whereas cells
grown on ﬂat plates in ﬁbroblast-like morphology. In three-dimensional
culture, the mRNA expression levels of COL1A1 and aggrecan were higher
than those in monolayer culture. And the cartilage matrix production in
three-dimensional culture was higher than that in monolayer culture.
Moreover, the production of MMP-3 induced by IL-1b and IL-6+sIL-6R was
higher in three-dimensional culture than in monolayer culture. Inhibitory
activity of HA on MMP-3 production was similar between three-dimen-
sional culture and monolayer culture. Over the subsequent passage, the
expression levels of COL1A1 and aggrecan mRNA and MMP-3 production
by IL-1b and IL-6+sIL-6R gradually decreased in monolayer culture, but
they remained at higher levels in three-dimensional culture.
Conclusions: In conclusion, the present study demonstrated that the novel
three-dimensional culture using micro-space plates maintains chondro-
genic properties. Three-dimensional culture using micro-space plates is
a useful tool for chondrocyte culture.
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A STUDY OF THE LOCAL RAS IN ATDC5 CHONDROPROGENITOR CELLS
AND EPIPHYSEAL PLATES OF MICE
I. Tsukamoto 1, M. Akagi 1, S. Inoue 1, T. Teramura 2, T. Takehara 2,
Y. Onodera 2, K. Hashimoto 1, C. Hamanishi 1. 1Dept. of Orthopaedic
Surgery, Faculty of medicine, Kinki Univ., Osaka-Sayama city, Japan;
2Divisin of Cell Biology for Regenerative Med., Inst. of Advanced Clinical
Med., Kinki Univ., Osaka-Sayama city, Japan
Purpose: Recently, the local renin-angiotensin system (RAS) has attracted
many researchers in many pathophysiological issues. In Orthopedics,
expression of local RAS was found in bone tissues, fracture callus and
arthritic synovium. The purpose of this study is to reveal immunohisto-
logical localization of the RAS components in the epiphyseal plates of mice
and to analyze function of the local RAS in the processes of hypertrophic
differentiation using ATDC5 chondroprogenitor cells.
Methods: The epiphyseal plates of 8-week-old mice was immunostained
with antibodies to angiotensinogen, angiotensinogen converting enzyme 1
(ACE1), angiotensinII type 1 receptor (AT1R) and angiotensinII type 2
receptor (AT2R). We cultured ATDC5 in long term and evaluated the
expression of angiotensinogen, ACE1, AT1R, AT2R and type 2 collagen
(COL2) by real- time PCR and Western blot analysis.
Results: In the epiphyseal plates of mice, angiotensinogen and AT1R
expressed in the resting chondrocytes, the proliferative chondrocytes and
hypertrophic chondrocytes ; however, ACE1 and AT2R expressed only in
the hypertrophic chondrocytes. In ATDC5 chondroprogenitor cells, the
local RAS components expressed both in proliferative and hypertrophic
differentiating stages.
Conclusions: The local RAS expresses in the epiphyseal plates of mice and
might play an important role in the process of hypertrophic differentiation.
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ESTROGEN'S STIMULATING EFFECT ON ATDC5
B. Lu, J. Dai, D. Shi, Q. Jiang. Ctr. of Diagnosis and Treatment for joint disease,
Nanjing, China
Purpose: The prevalence of knee osteoarthritis between Menopausal
woman increase sharply. There are many studies indicate that the level of
serum estrogen is associated with the morbidity of knee OA tightly. This
Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296S152study ,using the cell culturing technology, was to observe what different
results would come out from the MTTassay of the ATDC5 cell proliferation,
whick had been cultured with different concentration E2.
Methods: The 17-bestradiol we use was ordered from Sigma co. and the
ATDC5 cell line was form the Riken cell bank. We culture the ATDC5
24 hours in the media with different concentration 17-bestradiol, then we
test the OD value of the different cells in MTT assay to assume the prolif-
eration of the ATDC5.
Results: After culturing 24 hours in the media with different concen-
tration 17-bestradiol, the proliferation of the ATDC5 in different
concentration 17-bestradiol were different signiﬁcantly, the higher of the
concentration, the higher of the proliferation, as follows: beside the
10-11M against 0 M, the 10-10,10-9,10-8 and 10-7 M have signiﬁcant
difference in stimulating the proliferation of ATDC5 against 0 M. between
the different concentration groups, only 10-8 M has signiﬁcant difference
against 10-11,10-10 M.
Conclusions: First, 17-bestradiol has stimulation on the proliferation of
ATDC5.
Second, 10-8 M concentration of 17-bestradiol has the strongest stimu-
lating effect than the other concentration of 17-bestradiol.
Clinical Aspects / Outcomes
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PRE-OPERATIVE BMI AS A PREDICTOR OF PATIENT REPORTED
OUTCOMES OF PRIMARY HIP REPLACEMENT SURGERY: A COMBINED
ANALYSIS OF 4 PROSPECTIVE COHORT STUDIES
R.N. Batra 1, A. Judge 1,2, M.K. Javaid 1,2, G.E. Thomas 1, D. Beard 1,
D. Murray 1, P. Dieppe 3, K. Drienhoefer 4, K. Peter-Geunther 5,
R. Field 6, C. Cooper 1, N.K. Arden 1. 1NIHR BioMed. Res. Unit, Univ. of
Oxford, Oxford, United Kingdom; 2MRC Lifecourse Epidemiology Unit, Univ.
of Southampton, Southampton, United Kingdom; 3 Peninsula Coll. of Med.
and Dentistry, Plymouth, United Kingdom; 4Charité Univ.smedizin Berlin,
Dept. of Orthop., Traumatology and Sports Med., Berlin, Germany; 5Univ.
Hosp. Carl Gustav Carus, Technical Univ. of Dresden, Dresden, Germany;
6 Elective Orthop. Ctr., Epsom, United Kingdom
Purpose: Total hip replacement (THR) is a successful surgical intervention,
providing relief from pain, increasingmobility and improving quality of life
for majority of patients. Within the literature some, but not all studies,
have found that obesity is associated with worse patient reported
outcomes (PROMs) of THR, and there is increasing concern that obesity
may be used as a barrier to accessing surgery.
Methods: We obtained information from 4 prospective cohort studies of
patients receiving primary THR for osteoarthritis (OA): Exeter Primary
Outcomes Study (EPOS) (n¼1589); EUROHIP (n¼908); South West London
Elective Orthopaedic Centre (SWLEOC) (n¼1523); and St. Helier (n¼799).
The primary outcome was the 12 month Oxford Hip Score (OHS) which is
used to assess pain and function.For the EUROHIP study, we imputed the
OHS from WOMAC scores using truncated regression. Confounding vari-
ables included: age, sex, SF-36 mental health, comorbidities, ﬁxed ﬂexion,
analgesic use, college education, OA in other joints, expectation of less
pain, radiographic K&L grade, ASA grade, years of hip pain, deprivation.
Each study collected data on a different set of confounders; only age and
sex were available in all 4 cohorts. Linear regression (ANCOVA) is used to
describe the association of BMI on the 12 month OHS, adjusting for the
pre-operative OHS. Multiple imputation methods were used to handle
missing data. In order to combine data across the 4 studies we used two
methodological approaches:
a) Meta-Analysis - For each study, separate models are built to describe the
association of BMI on outcome. Models are adjusted only for age and sex in
order to construct related hypotheses in each study. Fixed effects meta-
analysis is used to combine the results;
b) Combining studies - Data from all 4 studies are combined using multiple
imputation methods to impute data on missing confounders, allowing the
association of BMI on outcome to be adjusted for all potential confounders.
Results: a) Meta-Analysis - Adjusting for age and sex, for a 5 unit increase
in BMI, the 12 month OHS decreases by 0.81 95%CI (0.55 - 1.08) units
(Figure 1);Ă
b) Combining Studies - Adjusting for age and sex alone, for a 5 unit increase
in BMI, the 12 month OHS decreases by 0.72 (0.46 - 0.99) units. Adjusting
for all potential confounders, the effect is attenuated to 0.51 (0.09 - 0.92).
Hence, for each 5 unit increase in BMI, the difference in post-op OHS
becomes larger and more important. For example, compared to people
with a normal BMI (20 - 25), those in the morbidly obese group (BMI 35 -
40) would have a post-op OHS that is 1.53 units lower. However, there is
a substantial improvement in OHS after THR across all BMI groups, which
greatly outweighs any difference in post-op score (Figure 2).
Ă
Conclusions: This study provides a comprehensive assessment of the
association of BMI on PROMs of THR. Its strength lies in the 4 large
prospective cohorts of patients used to assess THR outcome, and the use of
multiple imputation methods that allowed us to adjust for a wide range of
